Cardiac Progenitor Cells: The Matrix Has You

Area of Science:

• Cardiovascular Biology
• Regenerative Medicine
• Biomaterials Science

Background:

• The cardiac extracellular matrix (ECM) is dynamically remodeled by resident cells, providing crucial biochemical and mechanical signals.
• Heart failure pathology profoundly alters ECM composition and architecture, negatively impacting resident cell phenotypes.

Purpose of the Study:

• To discuss optimal scaffold features for cardiac tissue engineering using cardiac progenitor cells.
• To explore antifibrotic mechanisms mediated by cell therapy in the context of heart failure.

Main Methods:

• This perspective synthesizes current knowledge on the interplay between cardiac cells and the ECM.
• It reviews strategies for cardiac tissue engineering and cell-based therapies for heart failure.

Main Results:

• Optimal scaffolds must support cardiogenic commitment of therapeutic cells and minimize pro-fibrotic signals.
• Therapeutic cells possess the potential to counteract adverse ECM remodeling in heart failure.

Conclusions:

• Successful regenerative medicine for heart failure necessitates microenvironments that favor cardiac cell differentiation and combat fibrosis.
• Future strategies should integrate advanced biomaterials with cell therapy to restore cardiac function.